襄陽軸承(000678.SZ):預計2024年虧損3500萬元
格隆匯1月21日丨襄陽軸承(000678.SZ)公佈,預計2024年虧損3500萬元,扣非虧損4900萬元。本報吿期公司業績虧損,但幅度減小。一是國內公司業績提升、扭虧為盈。國內公司在乘用車市場和海外市場開拓取得顯著成效,營業收入同比增加,其中海外市場近幾年持續增長;公司管理效能提升,綜合降本取得實效,效益有較大增長。二是境外子公司虧損增加。境外波蘭工廠受地緣政治持續影響,成本費用居高不下,效益繼續下滑。公司已積極採取措施,調整波蘭工廠領導班子,制定改革方案,落實整改計劃,全力扭轉波蘭工廠不利局面。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.